APA (7th ed.) Citation

Bianchi, C., Alvarez-Castelao, B., Sebastián-Serrano, Á., Di Lauro, C., Soria-Tobar, L., Nicke, A., . . . Díaz-Hernández, M. (2023). P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer's disease. Alzheimer's Research & Therapy, 15(1), 1. https://doi.org/10.1186/s13195-023-01258-x

Chicago Style (17th ed.) Citation

Bianchi, Carolina, Beatriz Alvarez-Castelao, Álvaro Sebastián-Serrano, Caterina Di Lauro, Lucia Soria-Tobar, Annette Nicke, Tobias Engel, and Miguel Díaz-Hernández. "P2X7 Receptor Inhibition Ameliorates Ubiquitin–proteasome System Dysfunction Associated with Alzheimer's Disease." Alzheimer's Research & Therapy 15, no. 1 (2023): 1. https://doi.org/10.1186/s13195-023-01258-x.

MLA (9th ed.) Citation

Bianchi, Carolina, et al. "P2X7 Receptor Inhibition Ameliorates Ubiquitin–proteasome System Dysfunction Associated with Alzheimer's Disease." Alzheimer's Research & Therapy, vol. 15, no. 1, 2023, p. 1, https://doi.org/10.1186/s13195-023-01258-x.